Science Explorer Interactive view Map
Company · Marseille · France

Innate Pharma (France)

innate-pharma.com/en/introductionROR OpenAlex
World rank, all time
#10,112
of 42,892
Rank in France
#660
of 2,321
Research works
224
▼ 34% vs 2013–17
Citations
7.3k
32.5 per fractional work
Top-10% rate
16.7%
record average 16.5%
Open access
32%
world 28%

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.21× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 2.30× its world share, 3 worksBiochemistry, Geneti…Immunology and Microbiology: 28.69× its world share, 6 worksImmunology and Micro…Neuroscience: 0.71× its world share, 0 worksNeuroscienceChemistry: 0.71× its world share, 0 worksChemistryComputer Science: 0.30× its world share, 0 worksComputer ScienceEngineering: 0.13× its world share, 0 worksEngineeringEnvironmental Science: 0.62× its world share, 1 worksEnvironmental ScienceMaterials Science: 0.09× its world share, 0 worksMaterials ScienceMathematics: 0.56× its world share, 0 worksMathematicsHealth Professions: 0.06× its world share, 0 worksHealth ProfessionsMedicine: 2.16× its world share, 9 worksMedicineVeterinary: 1.17× its world share, 0 worksVeterinaryBusiness, Management and Accounting: 0.18× its world share, 0 worksBusiness, Management…Psychology: 1.14× its world share, 1 worksPsychologySocial Sciences: 0.11× its world share, 0 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 28.7×. Every wedge is a field page.

Who are the top researchers at Innate Pharma (France)?

Ranked on the composite score, Hélène Sicard and Pascale André lead among researchers whose main affiliation is Innate Pharma (France).

  1. 1 Hélène Sicard France · #471,794 worldwide 36 citations · 17 works
  2. 2 Pascale André France · #948,820 worldwide 34 citations · 16 works
All ranked researchers at Innate Pharma (France)

Which keywords describe research at Innate Pharma (France)?

By fractional works in 2022–2025, weighted toward what it does more of than the world: Lymphoma, Natural Killer Cells, NK Cell Recognition, Immunotherapy, Cancer Immunotherapy, Cancer, Leukemia and Tumor Regression.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 16 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 16 words, with their numbers
  1. Lymphoma2▲ 70×3 topics
  2. NK Cell Recognition2▲ 159×1 topic
  3. Natural Killer Cells2▲ 159×1 topic
  4. Immunotherapy2▲ 14×9 topics
  5. Cancer2▲ 6.9×10 topics
  6. Cancer Immunotherapy2▲ 58×3 topics
  7. Inflammation2▲ 4.2×13 topics
  8. Leukemia2▲ 103×2 topics
  9. Tumor Regression2▲ 75×2 topics
  10. CAR T Cells2▲ 110×1 topic
  11. Chimeric Antigen Receptor2▲ 110×1 topic
  12. Glycosylation2▲ 67×3 topics
  13. Autoimmunity1▲ 45×3 topics
  14. Epidemiology1▲ 1.27×9 topics
  15. Tumor Microenvironment1▲ 11×5 topics
  16. Targeted Therapy1▲ 21×5 topics

Which research topics does Innate Pharma (France) publish most on?

By volume in 2022–2025: Immune Cell Function and Interaction, CAR-T cell therapy research, Glycosylation and Glycoproteins Research and Galectins and Cancer Biology.

Immune Cell Function and…2Immune Cell Function and Interaction: 2 fractional worksCAR-T cell therapy research: 2 fractional worksGlycosylation and Glycoproteins Research: 1 fractional worksGalectins and Cancer Biology: 1 fractional worksMonoclonal and Polyclonal Antibodies Research: 1 fractional worksCancer Immunotherapy and Biomarkers: 1 fractional worksT-cell and B-cell Immunology: 1 fractional worksLymphoma Diagnosis and Treatment: 1 fractional worksToxin Mechanisms and Immunotoxins: 0 fractional worksIL-33, ST2, and ILC Pathways: 0 fractional works
ImmunologyOncologyMolecular BiologyRadiology, Nuclear Medicine and Imaging1 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Immune Cell Function and Interaction Immunology 2 works
  2. 2 CAR-T cell therapy research Oncology 2 works
  3. 3 Glycosylation and Glycoproteins Research Molecular Biology 1 works
  4. 4 Galectins and Cancer Biology Immunology 1 works
  5. 5 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 1 works
  6. 6 Cancer Immunotherapy and Biomarkers Oncology 1 works
  7. 7 T-cell and B-cell Immunology Immunology 1 works
  8. 8 Lymphoma Diagnosis and Treatment Pathology and Forensic Medicine 1 works
  9. 9 Toxin Mechanisms and Immunotoxins Immunology 0 works
  10. 10 IL-33, ST2, and ILC Pathways Immunology 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available32.3%not open67.7%

World: 28% of research is openly available.

with international co-authors41.0%domestic only59.0%

World: 19% is written across borders.

How has Innate Pharma (France)'s research output changed?

Output in 2018–2022 was 34% lower than in 2013–2017.

199520002005201020152020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Marseille

All research institutions in Marseille

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.